D.E. Shaw & Co’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
D.E. Shaw & Co's PCRX Position: Q3 2026 in Review
D.E. Shaw & Co reduced its Pacira BioSciences (PCRX) stake by 4% in Q3 2026, selling an estimated $1.97M and leaving 1,872,531 shares worth $46.9M. The position accounts for 0.02% of the portfolio, ranked #796.
D.E. Shaw & Co first reported a position in PCRX in Q2 2013 and has held it in 42 quarters since. The position peaked at $56.3M in Q1 2025. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- D.E. Shaw & Co held 1,872,531 shares of Pacira BioSciences worth $46.9M as of Q3 2026.
- D.E. Shaw & Co sold 77,801 Pacira BioSciences shares in Q3 2026, an estimated $1.97M.
- Pacira BioSciences made up 0.02% of D.E. Shaw & Co's portfolio in Q3 2026, its #796 holding.
- D.E. Shaw & Co first reported a position in Pacira BioSciences in Q2 2013 and has held it in 42 quarters since.
- D.E. Shaw & Co's Pacira BioSciences position peaked at $56.3M in Q1 2025.
- 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.